• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.根据甲状腺细胞病理学报告的贝塞斯达系统对甲状腺病变进行细胞形态学分类及其与组织学结果的相关性:一家印度肿瘤中心的经验
J Cytol. 2022 Jan-Mar;39(1):44-50. doi: 10.4103/JOC.JOC_79_20. Epub 2022 Jan 31.
2
Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution.甲状腺细胞病理学的贝塞斯达系统报告:在一所学术机构进行的为期两年的前瞻性研究。
Patholog Res Int. 2015;2015:240505. doi: 10.1155/2015/240505. Epub 2015 Jan 22.
3
A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.关于甲状腺细胞病理学报告的贝塞斯达系统不同诊断类别的恶性率研究:一项机构经验。
Biomed J. 2015 Dec;38(6):517-22. doi: 10.1016/j.bj.2015.08.001. Epub 2016 Mar 9.
4
To Establish Bethesda System for Diagnosis of Thyroid Nodules on the Basis of Fnac with Histopathological Correlation.基于细针穿刺活检(FNAC)并与组织病理学相关联建立甲状腺结节的贝塞斯达诊断系统。
J Clin Diagn Res. 2015 Dec;9(12):EC17-21. doi: 10.7860/JCDR/2015/14823.6897. Epub 2015 Dec 1.
5
Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.根据《甲状腺细胞病理学报告贝塞斯达系统》(TBSRTC)分类的发病率和恶性率——泰国一家三级中心的8年经验
J Clin Transl Endocrinol. 2018 Dec 14;16:100175. doi: 10.1016/j.jcte.2018.12.004. eCollection 2019 Jun.
6
Reproducibility of "The Bethesda System for Reporting Thyroid Cytopathology:" A Retrospective Analysis of 107 Patients.《贝塞斯达甲状腺细胞病理学报告系统》的可重复性:对107例患者的回顾性分析
J Cytol. 2018 Jan-Mar;35(1):33-36. doi: 10.4103/JOC.JOC_215_16.
7
Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective.基于甲状腺细胞病理学报告的贝塞斯达系统的甲状腺结节细胞形态学诊断的可重复性及恶性风险评估:三级癌症中心视角
J Microsc Ultrastruct. 2022 Dec 1;10(4):174-179. doi: 10.4103/jmau.jmau_88_21. eCollection 2022 Oct-Dec.
8
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
9
Unveiling Variations: A Comprehensive Comparison of Five Globally Used Thyroid Cytology Reporting Systems With Histopathological Correlation.揭示差异:五种全球常用甲状腺细胞病理学报告系统与组织病理学相关性的全面比较
Cureus. 2024 Feb 1;16(2):e53359. doi: 10.7759/cureus.53359. eCollection 2024 Feb.
10
Reproducibility of 'The Bethesda System for reporting Thyroid Cytopathology': A MultiCenter Study with Review of the Literature.《贝塞斯达甲状腺细胞病理学报告系统》的可重复性:一项多中心研究及文献综述
J Clin Diagn Res. 2013 Jun;7(6):1051-4. doi: 10.7860/JCDR/2013/5754.3087. Epub 2013 Jun 1.

引用本文的文献

1
Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights From a North Indian Tertiary Oncology Center.甲状腺病变的细胞组织形态学分析及恶性肿瘤/瘤形成的风险评估:来自印度北部一家三级肿瘤中心的见解
Cureus. 2025 Apr 24;17(4):e82959. doi: 10.7759/cureus.82959. eCollection 2025 Apr.

本文引用的文献

1
Thyroid Cytology in India: Contemporary Review and Meta-analysis.印度的甲状腺细胞学:当代综述与荟萃分析。
J Pathol Transl Med. 2017 Nov;51(6):533-547. doi: 10.4132/jptm.2017.08.04. Epub 2017 Oct 5.
2
Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.贝塞斯达不确定分类中的恶性肿瘤风险和瘤形成风险:对印度一家机构的4532例甲状腺细针穿刺抽吸术的研究
Acta Cytol. 2017;61(2):103-110. doi: 10.1159/000470825. Epub 2017 Apr 14.
3
The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions.哥伦比亚甲状腺细胞病理学报告的贝塞斯达系统:与肿瘤学和非肿瘤学机构组织病理学诊断的相关性。
J Cytol. 2015 Jan-Mar;32(1):12-6. doi: 10.4103/0970-9371.155224.
4
The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.贝塞斯达甲状腺细胞病理学报告系统:5年单中心经验
Ann Surg Oncol. 2014 Oct;21(11):3522-7. doi: 10.1245/s10434-014-3743-1. Epub 2014 May 6.
5
Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management.甲状腺乳头状癌滤泡变体:细针穿刺活检诊断的准确性及其对患者管理的意义
Endocr Pathol. 2014 Sep;25(3):257-64. doi: 10.1007/s12022-014-9301-3.
6
Implementation of the bethesda system for reporting thyroid cytopathology: interobserver concordance and reclassification of previously inconclusive aspirates.甲状腺细胞病理学报告的贝塞斯达系统的实施:观察者间一致性及对先前不确定抽吸物的重新分类
Diagn Cytopathol. 2014 Nov;42(11):944-9. doi: 10.1002/dc.23162. Epub 2014 Apr 1.
7
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.
8
The bethesda system for reporting thyroid cytopathology: interpretation and guidelines in surgical treatment.甲状腺细胞病理学报告的贝塞斯达系统:手术治疗中的解读与指南
Indian J Otolaryngol Head Neck Surg. 2012 Dec;64(4):305-11. doi: 10.1007/s12070-011-0289-4. Epub 2011 Aug 27.
9
Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system.在一个综合性学术和社区医院系统中实施 Bethesda 分类法前后甲状腺细针抽吸报告率和结果。
Arch Pathol Lab Med. 2013 Nov;137(11):1664-8. doi: 10.5858/arpa.2012-0366-OA.
10
Reproducibility of 'The Bethesda System for reporting Thyroid Cytopathology': A MultiCenter Study with Review of the Literature.《贝塞斯达甲状腺细胞病理学报告系统》的可重复性:一项多中心研究及文献综述
J Clin Diagn Res. 2013 Jun;7(6):1051-4. doi: 10.7860/JCDR/2013/5754.3087. Epub 2013 Jun 1.

根据甲状腺细胞病理学报告的贝塞斯达系统对甲状腺病变进行细胞形态学分类及其与组织学结果的相关性:一家印度肿瘤中心的经验

Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.

作者信息

Kamboj Meenakshi, Mehta Anurag, Pasricha Sunil, Gupta Gurudutt, Sharma Anila, Durga Garima

机构信息

Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.

出版信息

J Cytol. 2022 Jan-Mar;39(1):44-50. doi: 10.4103/JOC.JOC_79_20. Epub 2022 Jan 31.

DOI:10.4103/JOC.JOC_79_20
PMID:35341109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8955694/
Abstract

OBJECTIVE

The objective of this study was to report the experience of an Indian premiere tertiary care oncology center in reporting fine needle aspiration cytology of thyroid lesions according to the Bethesda system of reporting thyroid cytopathology (TBSRTC) given by National Cancer Institute (NCI). These were then correlated with their histopathological outcome, analyzing the level of specificity and sensitivity of the procedure.

MATERIAL AND METHODS

Aspiration cytology of thyroid lesions, presented during a 5.5-year duration, was reported retrospectively and prospectively, according TBSRTC, and correlated with their histopathologic diagnosis.

RESULTS

A total of 431 patients were evaluated comprising 289 females and 142 males, with a median age of 52 years. Among the cytological categories 80 (18.6%) were non-diagnostic (ND), 131 (30.2%) benign, 45 (10.4%) follicular lesion of undetermined significance (FLUS), 27 (6.3%) follicular neoplasm, 33 (7.9%) suspicious for malignancy (SM), and 115 (26.7%) malignant. Histopathology reports were available in 142 of these cases. Final malignant diagnosis was reported in 11 of 14 ND (78.6%), 5 of 18 benign cases (27.7%); 9 of 17 FLUS (52.9%), 7 of 13 FLUS (53.89%), 19 of 20 SM (95%), and 58 of 60 malignant cases (96.7%). The procedure had sensitivity of 94.4%, specificity of 61.9%, positive predictive value of 90.3% and negative predictive value of 72.22%.

CONCLUSION

TBSRTC provides uniform categorization of thyroid cytology, which also helps in further management. This valid system has helped to streamline the reporting terminologies as well as the clinical management.

摘要

目的

本研究的目的是报告一家印度一流的三级护理肿瘤中心根据美国国立癌症研究所(NCI)给出的甲状腺细胞病理学报告贝塞斯达系统(TBSRTC)报告甲状腺病变细针穿刺细胞学检查的经验。然后将这些结果与其组织病理学结果相关联,分析该检查方法的特异性和敏感性水平。

材料与方法

回顾性和前瞻性地报告了在5.5年期间出现的甲状腺病变的穿刺细胞学检查结果,并根据TBSRTC进行分类,同时将其与组织病理学诊断结果相关联。

结果

共评估了431例患者,其中女性289例,男性142例,中位年龄为52岁。在细胞学分类中,80例(18.6%)为非诊断性(ND),131例(30.2%)为良性,45例(10.4%)为意义未明的滤泡性病变(FLUS),27例(6.3%)为滤泡性肿瘤,33例(7.9%)为可疑恶性(SM),115例(26.7%)为恶性。其中142例病例有组织病理学报告。最终恶性诊断在14例ND中的11例(78.6%)、18例良性病例中的5例(27.7%)、17例FLUS中的9例(52.9%)、13例FLUS中的7例(53.89%)、20例SM中的19例(95%)以及60例恶性病例中的58例(96.7%)中得到报告。该检查方法的敏感性为94.4%,特异性为61.9%,阳性预测值为90.3%,阴性预测值为72.22%。

结论

TBSRTC为甲状腺细胞学提供了统一的分类,这也有助于进一步的管理。这个有效的系统有助于简化报告术语以及临床管理。